These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25875823)

  • 21. Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience.
    Kim JJ; Kim T; Lee H; Byun SS; Lee SE; Choe G; Hong SK
    PLoS One; 2018; 13(8):e0202872. PubMed ID: 30157232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
    Ekwueme K; Simpson H; Zakhour H; Parr NJ
    BJU Int; 2013 Jun; 111(8):E365-73. PubMed ID: 23714648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.
    Pereira RA; Costa RS; Muglia VF; Silva FF; Lajes JS; Dos Reis RB; Silva GE
    Asian J Androl; 2015; 17(5):815-20. PubMed ID: 25652629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Length of prostate biopsy cores: does it impact cancer detection?
    Fiset PO; Aprikian A; Brimo F
    Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods.
    Pan Y; Liu B; Huang Y; Wang J; Li X; Zhang C; Wu J; Zheng Y; Qin C; Cheng G; Hua L; Wang Z
    Oncotarget; 2017 May; 8(20):32930-32936. PubMed ID: 28380425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading.
    Terracciano D; Bruzzese D; Ferro M; Mazzarella C; Di Lorenzo G; Altieri V; Mariano A; Macchia V; Di Carlo A
    Prostate; 2012 Jan; 72(1):100-7. PubMed ID: 21520165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
    Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.
    Sinnott M; Falzarano SM; Hernandez AV; Jones JS; Klein EA; Zhou M; Magi-Galluzzi C
    Prostate; 2012 Aug; 72(11):1179-86. PubMed ID: 22161896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
    Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
    Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
    Oh JJ; Jeong SJ; Jeong CW; Byun SS; Hong SK; Choe G; Lee SE
    Prostate; 2013 Jan; 73(1):42-7. PubMed ID: 22585359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy.
    Lee WK; Lee S; Hong SK; Lee SE; Choi WS; Byun SS
    Int Braz J Urol; 2014; 40(4):484-92. PubMed ID: 25251953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.
    Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs.
    Kryvenko ON; Diaz M; Meier FA; Ramineni M; Menon M; Gupta NS
    Am J Clin Pathol; 2012 May; 137(5):739-46. PubMed ID: 22523212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: A propensity score-matched study.
    Jiang CY; Shen PF; Wang C; Gui HJ; Ruan Y; Zeng H; Xia SJ; Wei Q; Zhao FJ
    Asian J Androl; 2019; 21(6):612-617. PubMed ID: 31006712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.